Compound acting in spermatogenesis period and application thereof
By detecting the complex of SENP3, NPM1 and rRNA, the diagnosis of mammalian fertility defects, especially infertility disorders is solved, and effective diagnostic and treatment methods are provided to ensure the normal progress of the spermgenesis process.
Patent Information
- Application Number
- CN202310665900.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-05
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to effectively understand and detect fertility defects such as infertility disorders in mammals, especially humans, in vitro, especially during spermgenesis, which lead to difficulty in diagnosis and prediction.
Discovering and demonstrating that SENP3, NPM1 and rRNA-formed complexes control the formation of normal XY bodies and meiotic chromosome inactivation during spermgenesis provides methods for diagnosing or treating fertility defects, including the detection of these components. Gene and protein expression.
By detecting the presence and activity of SENP3, NPM1 and rRNA, it is possible to effectively diagnose and predict fertility defects, such as infertility disorders, in mammals, providing new treatments to avoid or correct these defects.
Smart Images

Figure CN119082281A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of diseases and diagnosis. Specifically, the present invention relates to methods and kits for diagnosing or treating fertility defects in mammals, especially humans. Background Art
[0002] In sexually reproducing organisms, meiosis is a special cell division mode that produces haploid gametes from diploid germ cells. During male spermatogenesis, homologous chromosome pairing and recombination occur in the prophase of meiosis, which can be divided into five substages according to chromosome structure: leptotene, pachytene, diplotene, and terminal metamorphosis. Subsequently, spermatocytes undergo two consecutive cell divisions to produce haploid spermatids; after protamine-histone exchange, mature spermatids are produced. In meiotic prophase I, unlike autosomes, most of the abnormal XY chromosomes are unsynaptic except for the "pseudoautosomal" region, but form a membrane-free spherical structure near the nuclear periphery that is obvious under microscopic observation, called the "XY body". In pachytene spermatocytes (PACs), the transcriptional silencing of unsynaptic XY chromosomes is called meiotic sex chromosome inactivation (MSCI), which is critical for normal meiosis and male fertility.
[0003] Unlike X chromosome inactivation (XCI) in female somatic cells, MSCI does not depend on Xist, the master regulator of XCI. Instead, increasing evidence suggests that DNA damage response (DDR) factors act as both sensors and effectors of silencing signals in the process of initiating MSCI, and mutations in DDR factors such as BRCA16, γH2AX7, ATR, and MDC18 severely impair this process. DDR factors also direct repressive histone modifications on XY chromosomes. For example, the histone methyltransferase SETDB1 mediates the transfer of H3K9me3 to XY chromosomes in a DDR-dependent manner, a process responsible for transcriptional inactivation and chromatin compaction at the onset of MSCI. As histone H3.1 / H3.2 is replaced by H3.3, H3K9me2 / 3 is lost in early to mid-PACs and restored in diplotene. Similarly, another repressive histone modification, H2AK119ub1, is also suppressed by SCML2-mediated deubiquitination of USP7.
[0004] The nucleolus is the largest membrane-free organelle assembled by liquid-liquid phase separation (LLPS) and is required for ribosome biogenesis. However, increasing evidence suggests that it also plays key roles in other biological processes, including DNA repair, stress response, genome organization, and transcriptional regulation. During meiotic prophase in spermatocytes, typical nucleoli are disassembled. Decades ago, it was reported that during meiotic prophase in mouse spermatocytes, nucleolar components migrate from autosomes to XY bodies and do not participate in RNA synthesis. However, the relationship between nucleolar migration and XY body formation and its function remain a mystery.
[0005] The field also needs to have a better understanding of the male spermatogenesis process in mammals, so as to detect and predict reproductive disorders such as infertility. Summary of the invention
[0006] The inventors have discovered and demonstrated for the first time that SENP3, NPM1 (and NPM3) and rRNA constitute a functionally interdependent complex during spermatogenesis, which controls the formation of normal XY bodies and meiotic sex chromosome inactivation (MSCI); abnormalities in the complex lead to abnormal spermatogenesis in mammals and even loss of male fertility. Thus, the inventors provide a method for diagnosing or treating fertility defects such as infertility in mammals, especially humans.
[0007] In one aspect of the present invention, a complex is provided, which includes: SENP3, NPM1 and rRNA. In another aspect of the present invention, the complex also includes NPM3. The present application found that SENP3, NPM1 and rRNA form a complex in pachytene spermatocytes, and the components are functionally interdependent. The complex can also be called a male-specific pachytene nucleolus-like body (mapNLB). In the complex, SENP3 deSUMOylates NPM1 and promotes its binding to rRNA.
[0008] In one aspect of the present invention, a combination is provided, which comprises: SENP3, NPM1 and rRNA. In another aspect of the present invention, the combination further comprises NPM3.
[0009] The present invention provides a method for diagnosing or predicting fertility defects such as infertility in a mammalian individual, which comprises detecting the above-mentioned complex or combination in the subject.
[0010] In the present invention, infertility disorders include but are not limited to teratozoospermia, azoospermia, oligozoospermia, asthenozoospermia, asthenozoospermia and the like.
[0011] In the present invention, the mammal can be any mammal, including and not limited to rodents, canines, felines, equines, ovines, bovines, porcines and primates. The mammal typically includes humans.
[0012] SENP3, or SUMO specific peptidase 3 (SENP3, also known as SUMO specific protease 3). The Senp3 gene encoding SENP3 is highly conserved in mammals. Among them, the human Senp3 gene Gene ID is 26168; the mouse Senp3 gene Gene ID is 80886.
[0013] NPM1 (nucleophosmin 1), also known as nuclear phosphoprotein, is a protein widely expressed in the nucleolus. It has been found that this protein can shuttle between the nucleus and the cytoplasm, participate in the assembly and transport of ribosomal proteins, and regulate the replication of centrosomes. The Npm1 gene encoding NPM1 is highly conserved in mammals. The Gene ID of the human Npm1 gene is 4869; the Gene ID of the mouse Npm1 gene is 18148.
[0014] NPM3 (nucleophosmin 3) is related to nuclear chaperonephosphoprotein, nucleoplasmin and nucleophosmin. This protein may function as a molecular chaperone in the cell nucleus, for example, as a molecular chaperone of NPM1. The Gene ID of the human Npm3 gene encoding NPM3 is 10360; the Gene ID of the mouse Npm3 gene is 18150.
[0015] In one aspect of the present invention, the method for diagnosing fertility defects provided by the present invention includes the step of detecting the genes of each component in the aforementioned complex, and the rRNA bound thereto, for example, detecting the genes Senp3 and Npm1 encoding SENP3 and NPM1. In another aspect of the present invention, the method also detects the rRNA bound to the complex. In another aspect of the present invention, the method also detects the gene Npm3 encoding NPM3.
[0016] The method for detecting genes used in the present invention is a method commonly used for detecting genes in the art and is not particularly limited. For example, mass spectrometry, microarray, sequencing, and detection methods using base sequence amplification methods such as PCR (polymerase chain reaction) can be cited.
[0017] In addition, the detection of PCR products obtained when PCR is performed using primers specific to each gene can be performed by any method commonly used to detect and quantify PCR products. For example, it can be detected by electrophoresis, by real-time PCR using fluorescent intercalators such as SYBR Green, or by single molecule fluorescence analysis.
[0018] The polynucleotide that can be used as the primer or probe for detecting gene is not particularly limited as long as it can be a polynucleotide that hybridizes with the partial region comprising the gene or its complementary strand. The design of polynucleotide can be carried out by any one of the well-known methods in the technical field. For example, it can be designed simply by utilizing known genome sequence data and universal primer design tool. As this primer design tool, for example, Primer3 that can be utilized on the network is arranged. In addition, known genome sequence data can be obtained in NCBI as an international base sequence database usually.
[0019] In one aspect of the present invention, the method for diagnosing fertility defects provided by the present invention includes the step of detecting each component protein in the aforementioned complex, such as the step of detecting SENP3 and NPM1. In another aspect of the present invention, the method also detects rRNA bound to the complex. In another aspect of the present invention, the method also detects the step of encoding NPM3. It includes detecting the expression of the protein (including whether it exists, and whether there is a phenomenon of reduced expression relative to normal or standard) or its activity.
[0020] In another aspect of the present invention, the method includes a step of determining the expression of each component protein in the aforementioned complex by immunoassay. For example, the expression of the target protein is detected by immunofluorescence or Western blotting with an antibody that specifically recognizes the protein. Another example is to detect the expression of the target protein by detecting the presence or amount of the mRNA of the protein, such as by RT-PCR to detect the amount of mRNA encoding the target protein in the sample. In another aspect of the present invention, the method includes a method for determining whether the protein forms a complex, such as an immunoprecipitation method.
[0021] In yet another aspect of the present invention, the method comprises the step of determining the activities of SENP3 and NPM1. In yet another aspect of the present invention, the method further comprises the step of detecting NPM3.
[0022] The present invention also provides a kit or instrument (including a gene chip) for diagnosing or predicting fertility defects such as infertility in mammalian individuals, which includes reagents for detecting each component protein or its gene in the aforementioned complex of the subject, as well as its bound rRNA.
[0023] In another aspect of the present invention, the kit or instrument includes reagents for detecting the expression or activity of each component protein in the aforementioned complex. For example, the kit or instrument includes reagents for immunoassay, such as reagents for detecting expression by ELISA or Western blot with antibodies that specifically recognize the protein. For another example, the kit or instrument includes reagents for detecting expression by detecting the presence or amount of mRNA for the protein, such as reagents for detecting the amount of encoding mRNA in a sample by RT-PCR.
[0024] In yet another aspect of the present invention, the kit or apparatus comprises reagents for detecting genes encoding each component protein in the aforementioned complex.
[0025] In one aspect of the present invention, in the above-mentioned method, kit or apparatus of the present invention, the reagent for detecting genetic markers in a sample includes primers or probes for detection, or reagents for checking mRNA, etc.
[0026] The present invention also provides the use of a reagent for detecting each component protein or its gene in the aforementioned complex, and its bound rRNA, in the preparation of a kit or instrument for diagnosing or predicting fertility defects such as infertility in mammals as described above.
[0027] The present invention also provides a method for treating or avoiding fertility defects in mammalian individuals, which includes treating individuals with male-specific pachytene nucleolus-like body (mapNLB) defects, such as defects in the constituent proteins or their genes in the aforementioned complex, and the rRNA bound thereto.
[0028] In this article, protein symbols are not italicized and are all capitalized; gene symbols are italicized. For example, SENP3 is a protein, and the gene encoding the protein is written as Senp3. Sometimes protein symbols are not italicized in this article. For example, sometimes "Senp3" in this article refers to SENP3 protein. Sometimes gene symbols are not italicized in this article. For example, sometimes "SENP3" or "SENP3 gene" in this article refers to the gene Senp3 encoding SENP3 protein. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1During spermatogenesis, the nucleolus migrates to the XY body during the meiotic prophase.
[0030] A. The mammalian nucleolus consists of three subregions: FC, DFC, and GC. Representative proteins: FC, UBF; DFC, FBL; GC, SENP3, and NPM1.
[0031] B. Localization of nuclear components in mouse spermatocytes at different stages of meiosis I. Large dots represent nuclei, and small dots represent XY bodies. Spermatocytes were counterstained with DAPI and γH2AX (XY body marker). Scale bar, 5 μm.
[0032] C. Localization of NPM1 and SENP3 in stage IX PACs and DIPs. Spermatocytes were counterstained with DAPI and γH2AX (XY body marker). Dashed circles indicate XY bodies. Scale bar, 5 μm.
[0033] D. Schematic model of the migration of nucleolar components. NPM1, SENP3, and rRNAs migrate from autosomal NORs to the XY body and transiently shield the entire XY body in PACs.
[0034] E. Localization of γH2AX and FBL in human PACs at stages I-III and IV-X. Spermatogonia were stained for γH2AX, FBL, and DAPI. Dashed circles indicate XY bodies. Scale bar, 5 μm.
[0035] F. Localization of γH2AX and NPM1 in human PACs at stages I-III and IV-X. Spermatogonia were stained for γH2AX, NPM1, and DAPI. Dashed circles indicate XY bodies. Scale bar, 5 μm.
[0036] Figure 2 Germ cell-specific depletion of SENP3 and NPM1 results in male infertility in mice.
[0037] AB Western blot analysis of Senp3 (A) or Npm1 (B) expression in adult Senp3SKO or Npm1SKO testes. ACTIN was used as a loading control.
[0038] CD adult WT and Senp3 SKO Mouse (C) or Npm1 SKO Representative testis images of mice (D).
[0039] EF WT and Senp3 SKO Male (E) or Npm1 SKO Hematoxylin staining of paraffin-embedded testis of male (F). Scale bar, 20 μm.
[0040] G. Adult WT and Senp3SKO Hematoxylin staining of paraffin-embedded testis sections from mice. The stage of the spermatic epithelial cell cycle is determined by the morphology of spermatocytes. Dashed circles indicate apoptotic premature spermatocytes. Scale bar, 10 μm.
[0041] H.WT and Senp3 SKO TUNEL assay of mouse testis sections, with nuclei counterstained with DAPI. Scale bar, 40 μm. Arrows indicate apoptotic premature spermatocytes. Asterisks indicate apoptotic elongated sperm at step 14.
[0042] Figure 3 SENP3, NPM1 and rRNA were shown to form mapNLB in spermatocytes.
[0043] A. Co-immunoprecipitation of SENP3-NPM1 interaction in mouse testis.
[0044] B. WT and Senp3 SKO Expression levels of NPM1 and SUMOylated NPM1 in mice.
[0045] C. RIP combined with RT-qPCR was used to analyze the adult Senp3 relative to WT. SKO Binding of SENP3 and NPM1 to 5.8S and 28S rRNA in mice. Anti-IgG was used as negative control.
[0046] D. Schematic representation of the model by which NPM1, SENP3 and rRNA interact and form the mapNLB complex.
[0047] E.NPM1 in Senp3 SKO Localization in mouse spermatids. Stages are indicated. Spermatids are stained with NPM1 (green), γH2AX (red), and DAPI (blue). γH2AX is a marker for the XY bodies of PAC. White dashed circles indicate XY bodies. Scale bar, 5 μm.
[0048] F. SENP3 in Npm1 SKO Localization in spermatids. Stages are indicated. Spermatids are stained with SENP3 (green), γH2AX (red), and DAPI (blue). γH2AX is a marker for the XY bodies of PAC. White dashed circles indicate XY bodies. Scale bar, 5 μm.
[0049] Figure 4 Deletion of Senp3 or Npm1 in spermatocytes impairs XY body formation.
[0050] A.γH2AX in WT and Senp3 SKO and Npm1 SKOLocalization of PACs. Cell nuclei were counterstained with DAPI. Various stages are shown in the figure. 1-2 rows, middle plane of Z-scan confocal images. 3D structure reconstructed by Imaris (https: / / imaris.oxinst.com / ). 4th row, 3D structure after adjusting the viewing angle. Scale bar, 5 μm.
[0051] B. SYCP3, SYCP1 and DPAI were used to treat WT and Senp3 SKO and Npm1 SKO Spermatocyte chromosome spreads from PACs were triple labeled. Dashed white circles indicate XY bodies. Scale bar, 5 μm.
[0052] C. Spermatocyte chromosome spreads of WT PACs were double labeled with SYCP3 and SYCP1. The enlarged image shows the XY body. The schematic diagram shows the typical XY body morphology of WT PACs.
[0053] D. Use SYCP3 and SYCP1 to target Senp3 SKO or Npm1 SKO Spermatocyte chromosome spreads from PACs are double labeled. Magnified to show XY bodies. Schematic diagram showing Senp3 SKO and Npm1 SKO Typical XY morphology of PACs.
[0054] E.WT and Senp3 SKO Heatmap of Hi-C interaction frequencies of mouse PACs on chromosome X (500 kb bins).
[0055] Figure 5 For mapNLB an MSCI of PACs is required.
[0056] A. Using SYCP3 and Pol II to detect WT and Senp3 SKO and Npm1 SKO Spermatocyte spreads from PACs were double labeled. Dashed circles indicate XY bodies. Scale bar, 5 μm.
[0057] B. Relative signal intensity analysis of Pol II / SYCP3 in early pachytene and metaphase PACs.
[0058] C. RNA-seq MA plot shows Senp3 SKO and Npm1 SKO Differentially expressed genes for autosomes and XY chromosomes between early and metaphase PACs compared with WT. Lighter dots are genes with no differential expression.
[0059] D. Boxplot showing the fold change of RNA for each gene on autosomes and chromosomes XY.
[0060] E. Venn diagram showing the role of Senp3 in RNA-seq experiments SKO and Npm1 SKO Overlap between upregulated genes in early and mid PACs.
[0061] Figure 6 Phase separation of NPM1 ejects Pol II from the XY body.
[0062] A. Effect of RNA on CTD incorporation into TBP droplets. LLPS of purified recombinant TBP and CTD with increasing concentrations of RNA (in 150 mM NaCl and 2.5% PEG). Scale bar, 5 μm. Results from three independent experiments are shown.
[0063] B. Effects of RNA and NPM1 protein on CTD incorporation into TBP droplets. LLPS of purified recombinant TBP, NPM1, and CTD in 150 mM NaCl and 2.5% PEG with increasing concentrations of RNA. Scale bar, 5 μm. Results from three independent experiments are shown.
[0064] C. Schematic diagram of the in vitro transcription assay.
[0065] D. In vitro transcription assay showing the transcriptional capacity of Pol II under the indicated conditions.
[0066] E. Schematic model showing that SENP3, NPM1, and rRNA form a functionally interdependent complex. SENP3 controls the precise migration of mapNLB to the XY body and determines the binding of NPM1 to rRNA, which in turn promotes the phase separation of NPM1. After NPM1 phase separation, Pol II is expelled, resulting in MSCI in the absence of H3K9me3.
[0067] Figure 7 SENP3 and NPM1 are essential for male fertility.
[0068] A. For creating conditional Senp3 SKO Schematic diagram of the gene targeting vector for mice. In the targeting vector, exons 3, 4, 5, 6, and 7 are surrounded by LoxP sites.
[0069] B. Used to create conditional Npm1 SKO Schematic diagram of the gene targeting vector for mice. In the targeting vector, exons 2, 3, 4, 5, and 6 are flanked by LoxP sites.
[0070] CD adult WT and Senp3SKO Mouse (C) or Npm1 SKO Hematoxylin staining of paraffin-embedded tail epididymis sections of mice (D). Scale bar, 50 μm.
[0071] Figure 8 These are the genes affected in Senp3 and Npm1 mutants.
[0072] A.Senp3 SKO and Npm1 SKO Gene ontology (GO) analysis of differentially expressed genes in early and mid PACs.
[0073] B. RNA-seq MA plots showing WT and Senp3 SKO Differentially expressed genes between autosomal and XY chromosome genes between DIPs. The light-colored dots in the middle are genes with no differential expression.
[0074] C. SENP3 expression in WT and SENP3 SKO Localization of stage VIII sperm tubules. The nucleoids were counterstained with DAPI. The enlarged image shows representative PACs of stage VIII sperm tubules. The dashed red circle indicates Senp3 SKO Residual SENP3 in PACs. Scale bar, 5 μm. DETAILED DESCRIPTION
[0075] The essential contents and beneficial effects of the present invention will be further described below in conjunction with embodiments, which are only used to illustrate the present invention rather than to limit the present invention.
[0076] Example 1 Experimental methods and reagents
[0077] Study participants
[0078] Written informed consent was obtained from all three participants. This study was approved by the Institutional Ethics Committee of Shandong University School of Medicine, approval number 2018-77, and by the Institutional Ethics Committee of Renji Hospital, Shanghai Jiao Tong University School of Medicine, approval number KY2021-173-B.
[0079] Mouse
[0080] All mice were housed in an animal facility under SPF conditions and fed regular food and water by facility staff in accordance with institutional guidelines and ethical regulations. The use of mice was approved by the Animal Ethics Committee of Shandong University School of Medicine. All animal care protocols were reviewed and approved by the Animal Use Committee of Shandong University School of Medicine. All animal experiments were performed in accordance with the approved Institutional Animal Care and Use Committee (IACUC) protocol (#2018-77) of Shandong University. All surgeries were performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.
[0081] Generation of CRISPR / Cas9-edited Senp3 conditional knockout mice
[0082] Senp3 conditional knockout mouse model was constructed by GemPharmatech (China). Exon 3 to exon 7 were selected as targets. Briefly, Cas9 mRNA and gRNA were transcribed in vitro. Cas9, sgRNA, and donor were microinjected into fertilized eggs of C57BL / 6J mice. F0 positive mice were obtained by transplantation of fertilized eggs, and confirmed by PCR and sequencing. A stable F1 generation mouse model was obtained by mating F0 generation positive mice with C57BL / 6J mice, and Senp3 was knocked out. flox / flox Crossbreeding Stra8-Cre mice to obtain germline-specific knockout mice. Stra8-Cre mice were provided by Professor Tong Minghan, an academician of the Chinese Academy of Sciences.
[0083] Generation of CRISPR / Cas9-edited Npm1 conditional knockout mice
[0084] The Npm1 conditional knockout mouse model was established by Cyagen (Suzhou, China). Exon 2 to exon 6 were selected as targets. Briefly, to design the targeting vector, the BAC clone RP23-26M12 was used as a template to generate homology arms and conditional knockout regions by PCR. Cas9, gRNA, and targeting vector were co-injected into fertilized eggs for conditional knockout mouse production. The pups were genotyped by PCR and then sequenced for analysis. Hybridization of Npm1 flox / flox Mice and Stra8-Cre mice were used to obtain germline-specific gene knockout mice.
[0085] Generation of CRISPR / Cas9-edited Mdc1 knockout mice
[0086] The Mdc1 knockout mouse model was created by Cyagen (Suzhou, China). Exon 5 to exon 7 were selected as the target site. Briefly, to design the targeting vector, the BAC clone RP23-23H7 was used as a template to generate homology arms and conditional knockout regions by PCR. Cas9, gRNA, and targeting vector were co-injected into fertilized eggs for conditional knockout mouse production. The pups were genotyped by PCR and then analyzed by sequencing.
[0087] Spermatocyte spreading and immunofluorescence staining
[0088] Mouse testicular cells were prepared for spreading and subsequent immunofluorescence staining as described previously. Briefly, seminiferous tubules were incubated in hypotonic extraction buffer [30 mM Tris (pH 8.2), 50 mM sucrose, 17 mM trisodium citrate, 5 mM EDTA, 2.5 mM dithiothreitol (DTT), and 1 mM phenylmethylsulfonyl fluoride (PMSF)] for 30 min at room temperature. Subsequently, cell suspensions were prepared in 100 mM sucrose and spread on slides in 1% PFA (pH 9.2) containing 0.15% Triton X-100. The slides were then placed in a humidified chamber for at least 1 h. Finally, the slides were washed twice for 3 min in 0.4% photo (Kodak) and air-dried at room temperature. The slides were either used immediately for immunofluorescence staining or stored at -80°C.
[0089] For immunofluorescence, slides were blocked with 1× phosphate-buffered saline (PBS) containing 5% BSA for 30 min. Slides were then incubated with primary antibodies in a humidified chamber overnight. Slides were then washed three times with 1× PBS. Secondary antibodies were applied for 1 h at room temperature in a humidified chamber. After secondary antibody incubation, three washes were performed in PBS and slides were mounted with Carrier Mounting Medium (H-1000, Carrier Laboratories).
[0090] Immunostaining, histology, and apoptosis analysis
[0091] Detection methods were performed according to standard protocols. For immunostaining, tissue sections were fixed with 4% paraformaldehyde (PFA) (Solarbio, Beijing, China, P1110), permeabilized with 0.1% Triton X-100 in PBS, and incubated with primary antibodies overnight at 4°C. After this, secondary antibodies conjugated with Alexa Fluor 488, 594, or 647 were added and incubated for 1 h at room temperature, and cell nuclei were counterstained with DAPI (Vector Laboratories). Images were taken using a dragonfly spinning disk confocal microscope driven by Fusion software, and projection images were prepared using Bitplane Imaris (version 8.1) software. The antibodies used are listed in Table S2 in the Supporting Information. For hematoxylin staining, testis, epididymis, and ovarian tissues were fixed in Bouin buffer, paraffin-embedded, and 5 μm paraffin-embedded testis or epididymis sections were sequentially dewaxed, rehydrated, and stained with hematoxylin. For TUNEL staining, the manufacturer's instructions were followed (keyGEN BioTECH, #KGA7072).
[0092] FISH
[0093] Frozen testis sections were used for RNA FISH analysis. RNA-FISH detection was performed according to the manufacturer's protocol provided by the Frozen Section Fluorescence In Situ Hybridization Kit (GenePharma). Briefly, the tissues were sectioned at a thickness of 5 μm after fixation with 4% paraformaldehyde and embedding with OCT. Frozen sections were incubated at room temperature for 15 min by adding buffer B to each section. Sections were incubated with proteinase K at 37°C for 20 min. Sections were blocked for 30 min by adding blocking buffer at 37°C and then denatured at 78°C for 8 min. After alcohol gradient dehydration, hybridization was performed in a FISH probe wet chamber at 37°C overnight in the dark. Sections were washed three times with wash buffer I (4× SSC 0.1% Tween-20, Sigma), followed by wash buffer II (2× SSC, Sigma) and wash buffer III (1× SSC, Sigma) at 42°C in the dark for 10 min. After the final wash, cells were stained with DAPI for 10 min in the dark. 5.8S and 28S FISH probes were designed and synthesized by RiboBio Ltd. All images were acquired using a confocal microscope driven by Fusion software.
[0094] Immunoprecipitation and immunoblotting
[0095] Immunoprecipitation and immunoblot analysis were performed using standard protocols. Briefly, mouse tissues or cells were homogenized in lysis buffer [50 mM Tris-HCl (pH 7.4), 120 mM NaCl, 20 mM NaF, 20 mM β-glycerophosphate, 1% NP-40, 1 mM EDTA, 6 mM EGTA, 1 mM DTT and protease inhibitor cocktail (Roche)]. Primary antibody-coupled protein A / G beads were added to the pre-cleared tissue or cell lysate and incubated overnight at 4°C. After washing in wash buffer [50 mM Tris-HCl (pH 7.4), 350 mM NaCl, 20 mM NaF, 20 mM β-glycerophosphate, 1% NP-40, 1 mM EDTA, 6 mM EGTA, 1 mM DTT), immunoprecipitated pellets or tissue / cell extracts were diluted in SDS loading buffer and then analyzed by liquid chromatography-tandem mass spectrometry (LC-MS / MS) or standard SDS-PAGE and immunoblotting procedures. Western blot images were captured by a Tanon-5200 chemiluminescent imaging system (Tanon).
[0096] Spermatocyte isolation
[0097] Testes were collected with PBS and placed on ice. After removing the tunica albuginea, testes were placed in PBS containing 120 U / mL type I collagenase at 32°C with gentle agitation for 5 min. Dispersed seminiferous tubules were then treated with 5 mL of 0.25% trypsin and 0.1 mL of DNase (5 mg / mL) by gently pipetting several times at 32°C for 8 min. 0.5 mL of fetal bovine serum (FBS) was added to inactivate trypsin to terminate the digestion. After two-step enzymatic digestion, the isolated testicular cell suspension was filtered through a PBS-pre-wetted cell strainer with a pore size of 70 μm. The cell suspension was centrifuged at 500 × g for 5 min at 4°C, and the supernatant was carefully removed from the pellet. The cells in the pellet were resuspended in DMEM at a concentration of 1 × 106 cells / mL while adding Hochest33342 (3 mg / mL) and 5 μl of RNase. To collect single cells, the cell suspension was plated in a 6-well plate at low density for 20 min at room temperature and single cells were selected based on fluorescent labels using the Unipick system. For FACS, the cell suspension was spun at 10 rpm (lowest speed) for 20 min at 32°C, then centrifuged at 500×g for 5 min at 4°C and resuspended in 0.3-1 mL DMEM for sorting. Cell populations were collected using the Hoechst 33342 fluorescent marker for flow cytometry.
[0098] Generation and sequencing of sisHi-C libraries
[0099] The sisHi-C library was generated as described in Turner, JMA Meiotic sex chromosome inactivation. Development 134, 1823-1831 (2007). SKOSpermatocytes were fixed with 1% formaldehyde (RT) for 10 min at room temperature. Formaldehyde was quenched with glycine for 10 min at room temperature. Cells were washed with PBS and then lysed on ice for 30-50 min in 50 μl lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM sodium chloride, 0.1 mM EDTA, 0.5% NP-40 and protease inhibitors). After centrifugation at 3500 rpm for 5 min at 4°C, the supernatant was discarded with a pipette. Chromatin was dissolved in 0.5% SDS and incubated at 62°C for 10 min. SDS was quenched with 10% Triton X-100 at 37°C for 15 min. Then the enzyme was spun down with 50 U MboI at 37°C overnight. MboI was then inactivated at 62°C for 20 min. To add the biotin tag to the DNA, dCTP, dGTP, dTTP, biotin-14-dATP, and Klenow were added to the solution and the reaction was rotated at 37°C for 1.5 h. The fragments were ligated for 4-6 h at RT with rotation. This was followed by reversal of crosslinking and DNA purification. The DNA was sheared to 300-500 bp using Covaris M220. The biotin-labeled DNA was then pulled down using 10 μl Dynabeads MyOne Streptavidin T1. The preparation of sequencing libraries was performed on the beads, including end repair, dATP tailing, and adapter ligation. 20 μl of water was added to the tube, eluted twice, and incubated at 66°C for 20 min. PCR amplification was performed for a total of 9-12 cycles using KAPA HiFi HotStart ReadyMix. Finally, size selection was performed using AMPure XP beads, selecting fragments of 200 bp to 1000 bp. All libraries were sequenced on Illumina NovaSeq according to the manufacturer's instructions.
[0100] Hi-C Data Mapping
[0101] Referring to the description in Ichijima, Y., Sin, HS & Namekawa, SH Se chromosome inactivation ingerm cells: emerging roles of DNA damage response pathways. Cell Mol Life Sci 69, 2559-2572 (2012), HiC-Pro (version 2.11.1) was used to align, process and iteratively correct the paired end raw reads of the Hi-C library. Briefly, the sequencing reads were first independently aligned to the mouse reference genome (mm9) using the bowtie2 end-to-end algorithm and the "-very-sensitive" option. In order to rescue chimeric fragments spanning the junction site, the junction site was detected and the 5' portion of the reads was aligned back to the reference genome. Unmapped reads, multi-mapped reads and singleton files were then discarded. The aligned reads were then assigned to the MboI restriction fragment. Read pairs were filtered out from uncut DNA, self-loop connections and PCR products, and a contact matrix was constructed using valid read pairs containing two different restriction fragments. The genome was then binned at a specific resolution by dividing it into bins of equal size. The binned interaction matrices were then normalized using an iterative correction method to correct for biases such as GC content, mappability, and effective fragment length in the Hi-C data.
[0102] RNA-Seq library preparation and sequencing
[0103] A total of 1 μg RNA per sample was used as input material for RNA sample preparation. Briefly, mRNA was purified from total RNA using magnetic beads attached to poly-T oligomers. Fragmentation was performed using divalent cations at high temperature in first-strand synthesis reaction buffer (5X). First-strand cDNA was synthesized using random hexamer primers and M-MuLV reverse transcriptase (RNase H-). Second-strand cDNA synthesis was subsequently performed using DNA polymerase I and RNase H. The remaining overhang was converted to blunt ends by exonuclease / polymerase activity. After adenylation of the 3′ end of the DNA fragments, adapters with hairpin loop structures were ligated in preparation for hybridization. In order to preferentially select cDNA fragments with a length of 370–420 bp, library fragments were purified using AMPure XP beads (Beckman Coulter, Beverly, USA). PCR was then performed using Phusion High-Fidelity DNA polymerase. Finally, PCR products were purified using AMPure XP beads, and library quality was assessed on an Agilent Bioanalyzer 2100 system. All libraries were then sequenced on a NovaSeq according to the manufacturer's instructions.
[0104] Analysis of RNA-seq datasets
[0105] Referring to Turner, JM et al. Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. J Cell Sci 115, 4097-4105 (2002), all RNA-seq data were mapped to the mm9 genome by HISAT2 (version 2.2.0). Based on the annotation mm9 refFlat database in the UCSC genome browser, StringTie (version 2.1.1) was used to calculate gene expression levels. Normalized differential expression analysis was performed using DESeq2. If the associated corrected p value is less than 0.05, it is called a differentially expressed gene. In order to compare the fold changes of autosomal and x-linked genes, only genes with per kilobase transcript fragment per million mapped exon reads (FPKM)>0.1 were considered.
[0106] RNA immunoprecipitation (RIP)
[0107] RIP assay was performed using RNA immunoprecipitation kit (Geneseed Biotech, China #P0101) according to the manufacturer's instructions. A total of 50 mg of tissue was lysed with buffer A on ice for 30 min, and 3 μg of antibody was used for immunoprecipitation in each RIP assay. TM cDNA was synthesized using RT reagent kit (Takara, RR037A) and then Premixed ExTaq TM qRT-PCR analysis was performed by (Takara, RR420A). Enrichment was calculated as a percentage relative to the input.
[0108] In vitro phase separation assay
[0109] Phase separation experiments were performed on confocal dishes (Nest). Purified proteins were diluted from high salt storage buffer into different concentrations of buffer containing 20 mM HEPES, pH 7.5, 150 mM sodium chloride, ± 2.5% PEG at the indicated protein concentrations. For co-phase separation experiments of NPM1 and total RNA / rRNA, total RNA was purified with TRIzol (Invitrogen) according to the manufacturer's instructions. rRNA was from BioWorld, 11020001-4. NPM1 protein and RNA were then gently mixed at the indicated concentrations and diluted from high salt storage buffer into physiological buffer containing 20 mM HEPES, pH 7.5 and 150 mM sodium chloride. After incubation for 30 min, all images were acquired by an Andor Dragonfly spinning disk confocal microscope driven by Fusion software.
[0110] In the droplet sedimentation experiment, samples were centrifuged at 14,000 rpm, 4°C for 10 min. Equal ratios of supernatant and pellet were used for immunoblot analysis. GFP-fused CTD was detected using anti-GFP antibody (PTG#50430-2-AP).
[0111] In vitro transcription
[0112] For in vitro transcription analysis, 1 unit of E. coli RNA polymerase (NEB), 250 nM of MBa and MBb probes, 50 nM of DNA template and indicator protein were mixed in transcription buffer (20 mM Tris pH 7.5, 30 mM magnesium chloride, 2.5 mM DTT and 5% glycerol) and incubated for 30 min. RNA synthesis was initiated by adding 250 μM NTP mixture and immediately placed in a RT-PCR thermal cycler for fluorescence detection at a constant temperature of 37 °C.
[0113] DNA sequence:
[0114] ctgaaatgagctgttgacaattaatcatcggctcgtataatgtgtgttggtgcggatatctcggtagtgggatacgacgataccgaagacagctcatgttatatcccgccgttaac caccatcaaacaggattttcgcctgctggggcaaaccagcgtggaccgcttgctgcaactctctcactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctg
[0115] MBA:5'FAMCTGTTTGATGGTGGTTAACGGCG
[0116] MBb:TTGCCCCAGCAGGCGAAAATC3'BHQ1
[0117] Statistical analysis
[0118] The statistical significance of the differences between the means of different genotypes was measured using a paired, two-tailed Student's t-test. Data were considered significant when the p value was less than 0.05.
[0119] Example 2 Migration of nuclides to XY bodies during meiotic prophase during spermatogenesis
[0120] The localization of each nucleosome component was analyzed by labeling the fibrillar center (FC) of the nucleosome with nucleolar transcription factor 1 (UBF), the dense fibrillar component (DFC) with FBL, and the granular complex (GC) with NPM1 and SENP324. Figure 1 A, B). In paraffin sections of mouse testes, spermatogonia A (SPA), intermediate spermatogonia (InSP), spermatogonia B (SPB), preleptotene spermatocytes (preLEPs), leptotene spermatocytes (LEPs), zygotene spermatocytes (ZYGs), pachytene spermatocytes (PACs), and diplotene spermatocytes (DIPs) were identified based on the cell associations observed in each seminiferous tubule cross section. All proteins examined were primarily localized in the autosomal nuclear origin regions (NORs) from SPA to LEPs. The signal for UBF subsequently decreased and disappeared from the ZYGs ( Figure 1 B). Unlike UBF, FBL gradually accumulates and begins to migrate from PACs to DIPs to the perichromosomal region (PR) of the XY body ( Figure 1 B). Strikingly, NPM1 covers the XY body (in about 85% of PACs) and then further migrates to the PR of the XY body in DIPs ( Figure 1 B). Similarly, SENP3, another component of GC, which regulates the SUMOylation status of NPM1 in HEK-293 cells, showed a similar distribution ( Figure 1 B). As a control, UBF (FC), FBL (DFC), SENP3, and NPM1 (GC) in precocious oocytes reside in nucleosomes and do not migrate, indicating that nucleosome disassembly and migration during the precocious stage of meiosis are male-specific.
[0121] These results show that nucleolar proteins dynamically migrate toward the XY bodies during the prophase of spermatocytes.
[0122] Example 3 NPM1, SENP3 and rRNA cover the XY body in pachytene spermatocytes (PACs)
[0123] Next, we investigated the migration of SENP3 and NPM1 to the XY bodies during a more detailed developmental time course by co-staining the XY body marker γH2aX and the acrosomal system marker lectin in mouse testis paraffin sections. Figure 1 C) Based on the stage of the seminiferous tubules, the pachytene stage is subdivided into 10 steps (stage IX), and accordingly they are divided into early (I-III), intermediate (IV-VII), and late (VIII-X) pachytene spermatocytes (PACs).
[0124] Similar to LEPs and ZYGs, SENP3 and NPM1 show scattered signals located in autosomal NORs in PACs stage I, and then gradually aggregate to cover the XY body from stage IV to stage X. At the beginning of diplotene, SENP3 and NPM1 move to the PR of the XY body and form a cap around the γH2aX signal ( Figure 1 C) It can be seen that in PACs, nucleolar migration is involved in XY body formation.
[0125] RNA FISH targeting 5.8S and 28S RNA sequences was used to examine the localization of RNA in mouse spermatocytes, and it was found that RNA was first located near RNAs in early PACs (stages I-III), near autosomal NORs, and then aggregated, migrated, and covered the XY body. These RNAs eventually formed a cap around the XY body in DIPs as well.
[0126] As can be seen, RNAs colocalize with SENP3 and NPM1 and cover the XY bodies in PACs ( Figure 1 D).
[0127] Example 4 Nucleolar migration in human pachytene spermatocytes (PACs)
[0128] By immunostaining of human spermatocytes, it was found that FBL and NPM1 first separated from the autosomes, aggregated, and then migrated to the XY body ( Figure 1 E, F). Similar to the results observed in mouse spermatocytes, NPM1 also covers the XY bodies in human stage IV-X PACs ( Figure 1 F).
[0129] Thus, the data suggest that nucleolar migration is conserved in humans and mice.
[0130] Example 5 SENP3 and NPM1 are essential for spermatogenesis and male fertility in mice
[0131] To determine whether SENP3 and NPM1 play a role in spermatogenesis, we investigated the role of SENP3 in spermatogenesis. flox / flox or Npm1 flox / flox Mice were crossed with Stra8-Cre transgenic mice to generate spermatocytes deficient in SENP3 or NPM1 ( Figure 7 A, B). The resulting germ cell-specific Senp3 and Npm1 knockout mice are called Senp3 SKO and Npm1 SKO By immunoblotting of whole testes, a significant reduction in SENP3 and NPM1 proteins was confirmed ( Figure 2 A, B). The residual SENP3 and NPM1 signals are presumably derived from supporting cells and interstitial cells. SKO and Npm1 SKO The male mice grew to adulthood and behaved normally. However, they were completely infertile because they did not produce pups after mating with wild-type (WT) females for more than 9 months. SKO and Npm1 SKO The testes of male mice are much smaller than those of WT mice ( Figure 2 C, D). Histological examination showed that Senp3 SKO and Npm1 SKO The diameter of the seminiferous tubules of male mice decreased by more than 50% ( Figure 2 E, F). About 96.4% of Senp3 SKO Spermatocytes were arrested in prophase I of meiosis, and almost no mature sperm were observed in the epididymal lumen. Figure 7 C) Senp3 SKO Male mice underwent apoptosis at stages III-V ( Figure 2 G), confirmed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) experiment ( Figure 2 H). Although a small number of spermatocytes survive after stage V pachytene, they die in stage 14 spermatids ( Figure 2 H). Similarly, all spermatocytes were arrested at the V pachytene stage in Npm1SKO male mice ( Figure 2 F), no mature sperm was observed in the epididymal lumen ( Figure 7 D) In contrast, Senp3 SKO Female mouse ovaries were morphologically comparable to WT mice and fertility was normal. SKO Female mice were infertile like male mutants, and oocytes were arrested at the GV stage after the diplotene stage of prophase I, suggesting that NPM1 may play a role in oocyte maturation.
[0132] Taken together, these results indicate that the male-specific functions of SENP3 and NPM1 during meiotic prophase I are essential for normal spermatogenesis and male fertility.
[0133] Example 6 SENP3, NPM1 and rRNA form male-specific pachytene nucleolar-like bodies (mapNLB) in spermatocytes
[0134] Immunoprecipitation analysis of WT mice showed that SENP3 and NPM1 were co-immunoprecipitated ( Figure 3 A), indicating a direct interaction. SUMOylated NPM1 protein is expressed in Senp3 SKO The level of NPM1 in spermatocytes increased by about 5 times compared with WT, while the total protein level of NPM1 remained basically unchanged ( Figure 3 B) These results indicate that SENP3 also binds to and deSUMOylates NPM1 in spermatocytes.
[0135] RNA immunoprecipitation (RIP)-qPCR confirmed that NPM1, but not SENP3, was closely associated with rRNA in WT spermatocytes ( Figure 3 C) It is worth noting that in Senp3 SKO In the presence of SENP3, the ability of NPM1 to bind rRNA was significantly reduced, indicating that deSUMOylation of NPM1 by SENP3 is essential for the interaction between NPM1 and RNAs.
[0136] Taken together, these data suggest that SENP3, NPM1, and rRNA form a functionally interdependent complex in PACs. The inventors call this complex the male-specific pachytene nucleolus-like body (mapNLB), in which SENP3 deSUMOylates NPM1 and promotes its binding to rRNA ( Figure 3 D).
[0137] Example 7 Deletion of Senp3 or Npm1 results in the separation of mapNLBs from XY bodies
[0138] Next, we investigated the effects of Senp3 and Npm1 knockout on nucleolar migration during spermatogenesis. Immunofluorescence analysis showed that the migration of FBL (nucleolar DFC) and TEX10 (ribosomal component) from autosomal NORs to XY body PRs was largely unaffected in both mutants. The localization of NPM1 and RNAs was also unaffected during the preleptotene to pachytene I stages after Senp3 knockout ( Figure 3E). However, in most stage IV-IX PACs, neither NPM1 nor RNA migrates precisely to the XY bodies. Instead, they are randomly distributed in the nucleus ( Figure 3 E). Notably, in about 28.7% of stages IV-IX, NPM1 and RNAs eventually migrated to the PR of the XY body ( Figure 3 E) and continued to the diploid stage. This is consistent with the observation that Senp3 SKO This is consistent with the results that a small number of spermatocytes escaped from thick line arrest. SKO In mice, no SENP3 or RNA signals were detected in the nuclei of spermatogonia and PACs; both migrated to the cytoplasm but not to the XY bodies ( Figure 3 E), indicating disassembly of mapNLBs. These data show that SENP3 and RNAs depend on NPM1 to enter the nucleus, which enables them to further aggregate and migrate to the XY bodies.
[0139] Taken together, these observations indicate that SENP3 and NPM1 are required for proper nucleolar migration toward the XY body.
[0140] Example 8: Abnormal XY body formation caused by rupture of mapNLBs
[0141] Next, the inventors investigated the role of mapNLBs in XY body formation. In WT mouse PACs, the extended XY chromosomes displayed by γH2AX gradually compressed into a condensed heterochromatic spheroid from the first stage, appearing as a sphere ( Figure 4 A) It is striking that although Senp3 SKO and Npm1 SKO The XY chromosomes in stage II-VI PACs also undergo dramatic condensation, as inferred from the doughnut-shaped signal in the largest scan surface (midplane) of the immunostaining images, and they appear as a hollow sphere ( Figure 4 A). Super-resolution structured illumination microscopy confirmed this observation. Three-dimensional (3D) reconstruction of γH2AX and DAPI immunofluorescence further revealed the abnormal structure of XY bodies in the mutant ( Figure 4 A).
[0142] Next, we examined the expression of WT, Senp3 SKO and Npm1 SKO XY bodies in spermatocyte chromosome spreads. Immunostaining for synaptic chromosome marker SYCP1 and chromosome axis marker SYCP3. Combined with DAPI signal, XY chromosomes show SYCP3 signal, while SYCP1 signal is very rare. Senp3 SKO and Npm1 SKOThe XY chromosomes cannot separate from the autosomes ( Figure 4 B). Regarding chromosome synapsis status and morphology, WTPACs showed fully synaptic autosomes and well-packed XY chromosomes ( Figure 4 C) However, Senp3 SKO and Npm1 SKO The XY chromosomes from most PACs were less compacted, and the average distance from the centromere from X to Y was twice that of the control group. Abnormal XY chromosomes can be divided into three groups: X chromosome synapsis with autosomes (11.27%), XY chromosome asynapsis (11.97%), and other XY abnormal morphologies (73.14%) ( Figure 4 D).
[0143] To better understand the spatial conformational changes of the XY body, WT and Senp3 SKO Consistent with the immunostaining data, Senp3 SKO This interaction is significantly reduced in Figure 4 E). Similarly, Npm1 SKO It shows abnormal XY chromosome morphology, X chromosome and autosome synapsis, or XY chromosome asynapsis ( Figure 4 D).
[0144] These data suggest that mapNLBs are involved in the formation of XY bodies in PACs.
[0145] Example 9: MSCI in PACs requires mapNLBs
[0146] Senp3 SKO and Npm1 SKO The mice showed a significant alteration in XY chromosome condensation, prompting the inventors to investigate whether MSCI was disturbed accordingly. In fact, unlike WT, RNA polymerase II (Pol II) was not activated by Senp3 SKO and Npm1 SKO The XY chromosomes of PACs are ejected ( Figure 5 A, B). Then, in FACS-purified WT and Senp3 SKO and Npm1 SKO RNA-seq was performed in early to mid PACs of Senp3 SKO There were 1942 and 1252 genes up-regulated and down-regulated in Npm1 SKOMore changes were found in the two mutants (up-regulated 3103, down-regulated 3262). In both mutants, the up-regulated genes were significantly concentrated in apoptosis, cell cycle and protein phosphorylation, while the down-regulated genes were mainly involved in sperm-related processes, including spermatogenesis, sperm development, cilia assembly and fertilization ( Figure 8 A).
[0147] These data are consistent with the critical roles of SENP3 and NPM1 for spermatocyte survival and development.
[0148] We next focused on XY chromosome genes. Strikingly, about half of the XY chromosome genes (378 and 463, respectively) were expressed in WT and Senp3 SKO and Npm1 SKO There are differentially expressed (DE) genes among the PACs. Among them, most of the XY chromosome genes are upregulated (Senp3 SKO 92.6% and Npm1 SKO 91.4%) Figure 5 C). This is in contrast to similar up- and down-regulated genes in autosomes (Senp3 SKO 56.5% vs. 43.5%; Npm1 SKO The proportions were 45.4% and 54.6% respectively)( Figure 5 C, D) Senp3 SKO 98.27% of the XY chromosome genes upregulated in PACs were in Npm1 SKO Overlapping mutants (Npm1 SKO 81.73% of the upregulated XY chromosome genes were in Senp3 SKO ), supporting the idea that SENP3 and NPM1 are interdependent ( Figure 5 E) Senp3 that escaped pachytene arrest was also collected. SKO RNA-seq data of DIP. Compared with WT cells, few XY-linked genes (24 genes) were affected ( Figure 8 B), the correct localization of NPM1 and rRNA, indicating that the residual SENP3 in this small fraction of cells (~5%) may be sufficient for MSCI ( Figure 8 C).
[0149] It can be seen that the disruption of mapNLBs leads to MSCI deficiency.
[0150] Example 10 Phase separation of NPM1 ejects Pol II from the XY body
[0151] LLPS of NPM1 in the presence of rRNA is considered to be the driving force for the formation of multilayered nucleolar structures. The observation that mapNLBs form spherical condensates within the XY body of PACs implies that the phase-separated NPM1 within mapNLBs may evict the transcription system from the XY chromosomes, which is also a liquid-phase-separated compartment formed by transcription factors and other related proteins. The inventors studied the effect of NPM1 phase separation on transcription condensates in vitro. Total RNA purified from mouse testes was successfully assembled into droplets with recombinant NPM1 protein. Over time, the droplet size gradually increased. When the RNA concentration increased, the droplet fusion rate was slower and the final volume was smaller, which means that the condensate of NPM1 has partial gel properties. Similarly, in vitro transcription initiation condensates were constructed using the C-terminal domain (CTD) of the largest subunit of RNA polymerase II (RPB1) and the TATA-box binding protein (TBP). Recombinant CTD (with 52 heptad repeats) was added to liquid-like TBP particles in the presence of 2.5% PEG ( Figure 6 A). This addition is not sensitive to the presence of high concentrations of RNA ( Figure 6 A). In the absence of TBP, the CTD remained in solution and could not be incorporated into NPM1 droplets, indicating that phase-separated NPM1 and CTD are mutually exclusive. To determine whether phase separation of NPM1 disrupts transcription initiation globules, NPM1 protein and RNA were added to solutions containing CTD-TBP compartments. Strikingly, this not only resulted in complete expulsion of the CTD from TBP concentrations, but also disrupted the TBP droplets ( Figure 6 B). Similar results were obtained by replacing TBP with PSPC1 (paraspeckle protein 1), which is involved in polymerase binding and transcription. Since PSPC1 is an RNA-binding protein, high levels of RNA resulted in small, irregular aggregation of PSPC1 droplets, and different RNA concentrations did not change the amount of bound CTD according to droplet sedimentation analysis. When RNA and NPM1 were added, PSPC1 droplets were severely disrupted and CTD was completely released.
[0152] These results indicate that phase separation of NPM1 disrupts the association of Pol II with transcription initiation condensates in vitro.
[0153] Next, the effect of NPM1 phase separation on transcription was investigated using a novel in vitro transcription system (described in Example 1) that includes a DNA template, Pol II, NTPs, and a binary fluorescence quencher (BFQ) probe that carries a donor and a quencher fluorophore, respectively. The sequences of the two probes are complementary to adjacent regions of the template. When they hybridize to newly synthesized mRNA, the donor and quencher fluorophores will be close enough to induce fluorescence resonance energy transfer (FRET) ( Figure 6 C). Therefore, the amount of mRNA produced will be proportional to the reduction in fluorescence signal. As a verification, the addition of TBP significantly reduced the amount of fluorescence signal compared to the control group ( Figure 6 D), which is consistent with TBP promoting transcription. It is worth noting that when NPM1 and RNA were added to the in vitro transcription system together, the fluorescence signal decreased much more slowly than the control group, indicating that the transcription rate was significantly reduced. In addition, NPM1 and RNA inhibited the promotion of transcription by TBP ( Figure 6 D). In contrast, addition of NPM1 or RNA alone only modestly inhibited transcription. Similar results were obtained by replacing TBP with PSPC1.
[0154] In summary, mapNLBs expels the transcriptional system on the XY chromosomes through phase separation of NPM1, resulting in transcriptional repression.
[0155] The inventors of the present application provided for the first time a spatiotemporal relationship on the dynamic redistribution of nucleolar components in the pre-spermatogenesis period, and discovered for the first time a male-specific pachytene nucleolus-like body (mapNLB) complex that is of great significance for the occurrence of meiotic sex chromosome inactivation (MSCI), which is a functionally interdependent complex formed by SENP3, NPM1 and rRNA in pachytene spermatocytes (PACs), in which SENP3 deSUMOylates NPM1 and promotes its binding to rRNA. The inventors discovered and demonstrated that mapNLBs are essential for mammalian spermatogenesis and male fertility: XY chromosomes of pachytene spermatocytes deficient in Senp3 and Npm1 exhibit morphological abnormalities and improper synapsis, fail to separate from autosomes, and exhibit transcriptional silencing disorders, demonstrating the role of mapNLBs in excluding transcriptional systems and causing the formation of heterochromatic membraneless organelles; Senp3 and Npm1 mutations lead to arrest and apoptosis of mid-pachytene spermatocytes, resulting in male infertility in mice. These results demonstrate the core role of mapNLBs in meiotic silencing. The inventors revealed for the first time the role of nucleolar components in transcriptional regulation after nucleolar disassembly in male meiosis.
[0156] Applicants have thus provided methods for diagnosing fertility defects such as infertility disorders in mammals, including humans, and further facilitated the development of new treatments for male infertile individuals affected by gene mutations.
[0157] The above is an explanation of the present invention and cannot be regarded as a limitation of the present invention. Unless otherwise noted, the practice of the present invention will use the conventional techniques of organic chemistry, polymer chemistry, biotechnology, etc., and it is obvious that the present invention can also be realized in other ways except that it is particularly described in the above description and embodiments. Other aspects and improvements within the scope of the present invention will be apparent to those skilled in the art to which the present invention belongs. According to the teachings of the present invention, many changes and variations are feasible, and therefore they are within the scope of the present invention.
Claims
1. A composite comprising: SENP3, NPM1 and rRNA. The complex according to claim 1 , further comprising NPM3.
3. A combination of: SENP3, NPM1 and rRNA.
4. The combination according to claim 3, further comprising NPM3.
5. A kit for diagnosing fertility defects such as infertility in mammals such as humans, comprising a reagent for detecting the complex according to any one of claims 1 to 2 or the combination according to any one of claims 3 to 4 in a subject.
6. The kit according to claim 5, wherein the infertility disorder is selected from teratozoospermia, azoospermia, oligozoospermia, asthenozoospermia, and asthenozoospermia.
7. The kit according to claim 5 or 6, wherein the detection reagent is a reagent for detecting Senp3, Npm1 and Npm3 genes, and optionally, it also detects rRNA.
8. The kit according to claim 5 or 6, wherein the detection reagent is a reagent for detecting SENP3, NPM1 and NPM3, and optionally, it also detects rRNA.
9. The kit according to claim 8, comprising reagents for detecting the expression of SENP3, NPM1 and NPM3 by immunoassay, such as ELISA or Western blotting by antibodies that specifically recognize the proteins; or These include reagents for detecting the presence or amount of mRNA of SENP3, NPM1 and NPM3, such as reagents for detecting the amount of mRNA encoding the protein in a sample by RT-PCR.
10. Use of a reagent for detecting the complex according to any one of claims 1 to 2 or the combination according to any one of claims 3 to 4 in a subject for preparing a kit or an apparatus for diagnosing or predicting fertility defects such as infertility disorders in mammals such as humans.
